A phase I trial of ANG1/2-Tie2 inhibitor trebaninib (AMG386) and temsirolimus in advanced solid tumors (PJC008/NCI#9041)

by Chiu, J.W, Hotte, S.J, Kollmannsberger, C.K, Renouf, D.J, Cescon, D.W, Hedley, D, Chow, S, Moscow, J, Chen, Z, Perry, M, Diaz-Padilla, I, Tan, D, Hirte, H, McWhirter, E, Chen, H, Siu, L.L, Bedard, P.L
Published 2020

Clinicopathological features and outcome of chronic lymphocytic leukaemia in Chinese patients

by Chan, T.S.-Y, Lee, Y.-S, Del Giudice, I, Marinelli, M, Ilari, C, Cafforio, L, Guarini, A, Tan, D, Phipps, C, Goh, Y.T, Hwang, W, Goh, A.Z.-K, Siu, L.L.-P, Wu, S, Ha, C.-Y, Lin, S.-Y, Kwok, C.-H, Lau, C.-K, Wong, K.-F, Foà, R, Kwong, Y.-L, Tse, E
Published 2020